References
Schiffer C, Hehlmann R, Larson R (2003) Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL(1). Leukemia 17:691–699
Fraunfelder FW, Solomon J, Druker BJ, Esmaeli B, Kuyl J (2003) Ocular side-effects associated with imatinib mesylate (Gleevec). J Ocul Pharmacol Ther 19:371–375
Kusumi E, Arakawa A, Kami M, Kato D, Yuji K, Kishi Y, Murashige N, Miyakoshi S, Ueyama J, Morinaga S, Taniguchi S, Muto Y (2004) Visual disturbance due to retinal edema as a complication of imatinib. Leukemia 18:1138–1139
Masood I, Negi A, Dua HS (2005) Imatinib as a cause of cystoid macular edema following uneventful phacoemulsification surgery. J Cataract Refract Surg 31:2427–2428
Robbins SG, Mixon RN, Wilson DJ, Hart CE, Robertson JE, Westra I, Planck SR, Rosenbaum JT (1994) Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 35:3649–3663
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Georgalas, I., Pavesio, C. & Ezra, E. Bilateral cystoid macular edema in a patient with chronic myeloid leukaemia under treatment with imanitib mesylate: report of an unusual side effect. Graefes Arch Clin Exp Ophthalmol 245, 1585–1586 (2007). https://doi.org/10.1007/s00417-007-0600-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-007-0600-y